9. 11. 2010
The aim of this study was to compare efficacy of antidepressant monotherapies and combinations of antidepressants in the treatment of resistant patients in current clinical practice.
We reviewed chart documents of resistant depressive inpatients treated at least 4 weeks with a new treatment. Depressive symptoms and clinical status were assessed using Montgomery and Åsberg Depression Rating Scale (MADRS), Beck Depression Inventory–Short Form and Clinical Global Impression at the baseline, week 2 and in the end of treatment.
We identified 81 patients (27 with combinations and 51 with monotherapies) that were suitable for analyses. The combination group achieved higher reduction of MADRS score (14.6 vs 10.2 pts., p=0.02) and response rate (50% reduction of MADRS, 67% vs 39%, p=0.03). Number needed to treat for response was 4.
Based on our results, we suggest that combination of antidepressants might be more effective than monotherapy in clinical practice.